
Investigational New Drug CDMO Market by Service Type (Analytical Testing, Clinical Trial Material Manufacturing, Commercial Manufacturing), Molecule Type (Biologics, Gene Therapy, Peptides), Therapeutic Area, Scale, Manufacturing Type, Licensing Model, Customer Type - Global Forecast 2026-2032
SKU
MRR-9C4233EE5E2A
Region
Global
Publication Date
June 2026
Delivery
Immediate
2025
USD 787.88 million
2026
USD 846.82 million
2032
USD 1,397.23 million
CAGR
8.52%



